A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers world-wide.
Our technologies and products are making studies possible that were not imaginable just a few years ago. Our renowned chromatin researchers possess expertise and unique insight into chromatin biology and drug discovery that benefit our customers in ways other companies cannot.
Epigenetics, the study of changes in heritable traits that occur independent of alterations in changes in the underlying DNA sequence, is an emerging and important area of biomedical research with broad impact on human health and disease.
Company Details
- Employees
- 53
- Founded
- -
- Address
- 801 Capitola Drive,
- Phone
- (855) 374-2461
- in****@****her.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- epicypher.com
- Keywords
- epigenetics, chromatin, histone, nucleosome, histone modification, histone methylation, histone acetylation, histone binding proteins, epigenomics, recombinant nucleosome, designer nucleosome, drug discovery, SPIKE-IN, ChIP, Chromatin Immunoprecipitation, High Throughput Assay Development.
- HQ
- Durham, North Carolina
Epicypher, Inc. Questions
Epicypher, Inc.'s helpline number is (855) 374-2461
Epicypher, Inc.'s website is epicypher.com
Epicypher, Inc.'s LinkedIn profile is https://www.linkedin.com/company/epicypher
Epicypher, Inc. has
53 employees.
View email and phone details for 53
employees at Epicypher, Inc..
Epicypher, Inc.'s industry is
Biotechnology Research
Epicypher, Inc.'s top competitors are
New England Biolabs,
Clara Biotech,
Parse Biosciences,
Illumina,
Celldom, Inc.,
Precision Biosciences, Inc.,
Active Motif,
Scale Biosciences,
Thermo Fisher Scientific,
Bioskryb Genomics.
Epicypher, Inc.'s support email address is info@epicypher.com
Epicypher, Inc.'s categories are Biotechnology Research
Epicypher, Inc.'s founding year is 2012
